(IN BRIEF) Evonik has partnered with Zurich-based evitria to offer the eviCHO Expression Kit, a ready-to-use transient protein expression kit based on CHO cells for biopharmaceutical research and development. The kit is designed to simplify workflows, reduce troubleshooting and support … Read the full press release
Posted in Business, Chemicals, Germany, Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged Advance Precision Biosolutions, amino acids, antibodies, antibody expression, antibody-based molecules, Atlas Antibodies group, biologics development, biomanufacturing, biopharma customers, biopharmaceutical research, chemically defined ingredients, Chinese Hamster Ovary cells, CHO cells, CHO-K1 cells, dipeptides, eviCHO Expression Kit, eviCHO Expression Kit Aims to Simplify Transient Protein Production for Biopharma Research, evitria, Evonik, Evonik and evitria Launch Ready-to-Use CHO-Based Protein Expression Kit, Evonik Expands Precision Biosolutions Portfolio Through evitria Partnership, Guido Skudlarek, InVitria, lipids, non-animal-derived ingredients, protein production, recombinant human serum albumin, rHSA, Stefan Schmidt, surfactants, Switzerland, transient protein expression, Zurich
(IN BRIEF) Evonik has partnered with ST Pharm to enhance its RNA and nucleic acid therapeutic services, combining ST Pharm’s expertise in customized nucleic acids with Evonik’s advanced lipid and lipid nanoparticle (LNP) drug product development solutions. This collaboration aims … Read the full press release
Posted in Business, Chemicals, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged active ingredients, capping library screening, clinical trials, drug delivery, drug development, drug product development, enzymatic biotransformation, Evonik, Evonik capabilities, Fill & Finish, gene delivery, gene therapies, GMP manufacturing, Health Care Business, Kris S. Choi, life sciences sector, lipid nanoparticle, lipids, liposomes, LNP, mRNA development, mRNA-LNPs, North America manufacturing, nucleic acid medicines, nucleic acid therapeutics, nucleic acid therapies, Nutrition & Care division, oligonucleotides, partnership, pharmaceutical companies, RNA market, RNA therapeutics, siRNAs, small molecules, SmartCap® technology, South Korea, ST Pharm, strategic partnership, Yann d'Hervé
(IN BRIEF) Evonik has partnered with the University of Mainz to commercialize a new class of polyethylene glycols (PEGs) called randomized polyethylene glycols (rPEGs). These rPEGs will be integrated into Evonik’s specialized lipid platform for drug delivery in nucleic acid-based … Read the full press release
Posted in Chemicals, Germany, Healthcare, Pharma & Biotech, Science, Technology
Tagged Evonik, immunogenicity, lipid, lipid nanoparticle carriers, lipids, LNP carriers, nucleic acid delivery, nucleic acid-based medicines, PEGs, Polyethylene glycols, polymers, Prof. Dr. Holger Frey, randomized polyethylene glycols, rPEG lipids, rPEG-lipids, rPEGs, specialty chemicals, Thomas Riermeier, University of Mainz
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?